Researchers at University of California San Diego School of Medicine have shown that ozanimod (RPC1063), a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. Results of the Phase II clinical trial will appear in the May 5 issue of the New England Journal of Medicine.
The University of California San Diego is named the 35th best university in the world, according to Times Higher Education which released its World Reputation Rankings today. The campus moved up five spots compared to last year’s list.
The sea urchin’s intricate mouth and teeth are the model for a claw-like device developed by a team of engineers and marine biologists at the University of California, San Diego to sample sediments on other planets, such as Mars. The researchers detail their work in a recent issue of the Journal of Visualized Experiments.
Chemists at UC San Diego have developed a new tool that allows scientists for the first time to see, at the scale of five billionths of a meter, “nanoscale” mixing processes occurring in liquids.
Two researchers with the San Diego Supercomputer Center (SDSC) at the University of California San Diego are editors of a just-published book that explores the latest developments in electronic structure calculations on modern computer hardware and explains how graphics processing units (GPUs) can be efficiently exploited to perform such calculations more rapidly than previously possible.
Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
